Published online Apr 10, 2016. doi: 10.5306/wjco.v7.i2.155
Peer-review started: July 7, 2015
First decision: September 22, 2015
Revised: October 19, 2015
Accepted: December 17, 2015
Article in press: December 18, 2015
Published online: April 10, 2016
Processing time: 280 Days and 17.7 Hours
In many clinical studies, laparoscopic surgery (LS) for colon cancer has been shown to be less invasive than open surgery (OS) while maintaining similar safety. Furthermore, there are no significant differences between LS and OS in long-term outcomes. Thus, LS has been accepted as one of the standard treatments for colon cancer. In the treatments of rectal cancer as well, LS has achieved favorable outcomes, with many reports showing long-term outcomes comparable to those of OS. Furthermore, the magnification in laparoscopy improves visualization in the pelvic cavity and facilitates precise manipulation, as well as providing excellent educational effects. For these reasons, rectal cancer has seemed to be well indicated for LS, as has been colon cancer. The indication for LS in the treatment of locally advanced rectal cancer, which is relatively unresectable (e.g., cancer invading other organs), remains an open issue. In recent years, new techniques such as single-port and robotic surgery have begun to be introduced for LS. Presently, various clinical studies in our country as well as in most Western countries have demonstrated that LS, with these new techniques, are gradually showing long-term outcomes.
Core tip: Our findings describe the merits of laparoscopic surgery (LS) over open surgery. We present some new LS techniques. We conclude with an explanation of the safety and curability of LS for colorectal cancer.